Company intelligence / Profile preview

Genase

Mountain View, California, United States

Ownership: Private
Development stage: Other

Overview

Genase was a biotechnology company primarily known for its development of enzyme-based therapeutic products. The company's lead product was a recombinant human deoxyribonuclease I (rhDNase), which was developed to treat the respiratory complications associated with cystic fibrosis by thinning the thick mucus in the lungs. Genase's technology focused on the production and formulation of recombinant enzymes for clinical use. The company was eventually acquired, and its primary technology and product candidates were integrated into the acquirer's respiratory and orphan drug portfolios.

Therapeutic areas: Pulmonology
Modalities: Enzyme replacement therapyProteinRecombinant protein
Industry: Biotech

Beyond the preview

Go deeper on Genase.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genase.

Explore the full profile